印度第四大制药公司MankindPharmaLtd.(MANKIND.IN)印度IPO首日收涨31.69%,报1422.30(卢比),临近收盘时曾涨至1430.00——市值达到5728亿卢比(折合将近70亿美元),为印度2023年迄今最大IP... 快讯正文 印度第四大制药公司MankindPharmaLtd.(MANKIND.IN)印度IPO首日收涨31.69%,报1422.30(卢比),临近收盘时曾涨至1430.00...
Latest Mankind News Titan, Dr. Reddy's, Berger Paints, Mankind Pharma, KEC, ABB, Sai Silk And More Q2 Review: HDFC Securities Nov 6, 2024 A trader monitoring stock data. (Source: Dragos Condrea/ freepik) NDTV Profit’s special research section collates quality and in-depth equity and ec...
Check Mankind Pharma Share Price ₹2745.00 Today: Evaluate if Mankind Pharma is Overvalued or Not, Access Valuation, Financials and Fundamental Analysis for informed investment decisions with up-to-date insights.
Mankind Pharma Enters Into Agri-Tech Segment With Launch Of Agritech “We are happy to announce our launch in the agritech domain with long-term investment plans, with an initial (Rs) 150 to (Rs) 200 crore capex infusion in the first two to three years,” Mankind Pharma Managing Director...
印度第四大制药公司MankindPharmaLtd.(MANKIND.IN)印度IPO首日收涨31.69%,报1422.30(卢比),临近收盘时曾涨至1430.00——市值达到5728亿卢比(折合将近70亿美元),为印度2023年迄今最大IPO。该公司2007年进入消费者保健行业,此后在避孕套、妊娠检测、紧急避孕药、抗酸粉、维生素和矿物质补充剂以及抗痤疮制剂类别中建立了...